HCID 66715383, compound → HCID 66715592, compound

HRID 2271873Notes

Reaction equation

HRID 2271873 reaction equation
Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12]([CH:14]1[CH2:16][CH2:15]1)=[O:13])=[C:5]2[NH:17][C:18]1[CH:23]=[CH:22][C:21]([CH2:24][CH2:25][N:26]([CH3:28])[CH3:27])=[CH:20][CH:19]=1.[Cl:29][C:30]1[CH:35]=[C:34](B2OC(C)(C)C(C)(C)O2)[CH:33]=[C:32]([F:45])[C:31]=1[OH:46]>>[Cl:29][C:30]1[CH:35]=[C:34]([C:2]2[CH:3]=[C:4]3[C:9](=[CH:10][CH:11]=2)[N:8]=[CH:7][C:6]([C:12]([CH:14]2[CH2:15][CH2:16]2)=[O:13])=[C:5]3[NH:17][C:18]2[CH:23]=[CH:22][C:21]([CH2:24][CH2:25][N:26]([CH3:27])[CH3:28])=[CH:20][CH:19]=2)[CH:33]=[C:32]([F:45])[C:31]=1[OH:46]

Participants

3

Procedure

Following general procedure D, (6-bromo-4-(4-(2-(dimethylamino)ethyl)phenylamino)quinolin-3-yl)(cyclopropyl)methanone (100 mg, 0.23 mmol) was reacted with 2-chloro-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (93 mg, 0.34 mmol) to afford the desired product (83 mg, 72%) as a yellow-brown solid: 1H NMR (500 MHz, CD3OD+TFA-d) δ 9.46 (s, 1H), 8.21 (dd, J=8.8, 1.9 Hz, 1H), 8.01 (d, J=8.8 Hz, 1H), 7.89 (s, 1H), 7.57 (d, J=8.4 Hz, 2H), 7.47 (d, J=8.4 Hz, 2H), 7.04 (m, 2H), 3.41 (m, 2H), 3.21 (m, 2H), 2.99 (s, 7H), 2.90 (m, 1H), 1.23 (m, 4H); ESI MS m/z 504 [C29H27ClFN3O2+H]+; HPLC 97.0% (AUC), tR=10.95 min.

Sources & evidence

ORD record
ord-f2fc07882b1745499a72eb14844f0c9d
Source dataset
uspto-grants-2015_09
Patent number
US09120749B2

Reaction notes

Loading…